Journal for ImmunoTherapy of Cancer (Nov 2023)
1028 Ex vivo chemotherapy resistance of metabolically reprogrammed autologous Th1/Tc1 cells (RAPA-201): Towards the clinical translation of immune-sparing host conditioning
Abstract
No abstracts available.